Thu, Jan. 14, 4:23 PM
- At the special meeting of MedAssets (NASDAQ:MDAS) shareholders today, almost all (99.8%) of the votes cast, representing 89.7% of the total shares outstanding, favored the company's acquisition by Pamplona Capital Management LLP for $31.35 per share in cash ($2.7B). The deal should close by the end of the month.
- Previously: Pamplona Capital buys MedAssets for $2.7B (Nov. 2, 2015)
Nov. 2, 2015, 8:23 AM
- Pamplona Capital Management acquires MedAssets (NASDAQ:MDAS) for $31.35 per share in cash or ~$2.7B. Pamplona partner Jeremy Gelber, M.D., says, "We are excited to be acquiring this leading healthcare performance improvement platform company that serves four out every five hospitals in the U.S. As a next step to our strategy, we plan to combine the MedAssets Revenue Cycle Management (RCM) segment with our Precyse business to create a leading, end-to-end revenue cycle technology and services business. At the same time, we intend to sell the MedAssets Spend and Clinical resource Management (SCM) business to VHA-UHC Alliance. In each case, we believe these business combinations will enable greater innovation and scale to deliver enhanced clinical, operational and financial performance improvement to positively impact healthcare organizations' outcomes."
- The financial terms of the sales to VHA-UHC are not disclosed. The transaction should close in early 2016.
Aug. 13, 2014, 5:02 PM
- MedAssets (MDAS +1.5%) enters into a definitive agreement to acquire privately-held SG-2, LLC for ~$142M in cash. SG-2 provides healthcare market intelligence, strategic analytics and clinical consulting services to hospitals and health systems as well as pharma and device companies.
- MedAssets will fund the transaction with cash on hand and borrowings under its existing credit facility. It is expected to close in 60 - 90 days.
Feb. 14, 2012, 9:16 AM